Hemodynamics, fluids & transfusion

Evaluating Three Routes of Tranexamic Acid Administration in Total Hip and Knee Arthroplasty: A Nationwide Database Analysis in Taiwan

AnesthesiologyPublished Retrospective cohort study

Authors' conclusion

TXA use was associated with substantial transfusion reduction without an overall increase in adverse events. No administration route or combination proved superior.

Study context

Population
Patients undergoing unilateral total hip or knee arthroplasty, Taiwan national health insurance database (2012 to 2021)
Exposure
Topical, IV and oral tranexamic acid (TXA) vs no TXA, and between routes
Outcome
Erythrocyte transfusion
Methodological detailsnationwide database, propensity score-matched comparisons, conditional logistic regression
  • Nationwide database
  • Propensity score-matched comparisons
  • Conditional logistic regression

Main finding

As reported in the abstract

Relative risk (95% CI)P value
Topical vs No TXA
0.45(0.41–0.48)
P < 0.001
IV vs No TXA
0.80(0.79–0.84)
P < 0.001
Oral vs No TXA
0.82(0.73–0.92)
P = 0.007
Topical vs IV
1.09(0.96–1.24)
P > 0.999

Observational data: associations, not effects.

Further findings

Predicted transfusion risk, topical TXA at low dose (0 to 3.0 g)

Greatest reduction in predicted transfusion risk
−3,087 per 10,000 [−2,886, −3,276]

Safety

Venous thromboembolism (VTE), infections, wound complications · 60 days after discharge

TXA use not associated with increased VTE, infections or wound complications overall
Higher VTE incidence with topical TXA in patients with previous vascular disease without pharmacologic prophylaxis; not significant after adjustment

Renal injury · 60 days after discharge

High-dose IV (>3.0 g) or oral (>8.0 g) TXA increased predicted risk in preexisting renal disease
≈10%
Not associated overall

Original publication

Evaluating Three Routes of Tranexamic Acid Administration in Total Hip and Knee Arthroplasty: A Nationwide Database Analysis in Taiwan. Anesthesiology. Published 4 May 2026. doi:10.1097/aln.0000000000006114

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.